Vicapsys Life Sciences, Inc.
VICP
$1.77
$0.5039.37%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -235.50K | -190.10K | -327.10K | -594.80K | -240.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 22.70K | 0.00 | 27.80K | 51.40K | 62.20K |
| Total Other Non-Cash Items | 0.00 | 0.00 | 86.30K | 0.00 | 18.60K |
| Change in Net Operating Assets | 172.30K | 196.30K | 203.50K | 461.30K | 52.00K |
| Cash from Operations | -40.40K | 6.20K | -9.40K | -82.10K | -107.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 130.00K | -- | -- | -23.50K | -54.90K |
| Total Debt Repaid | 0.00 | -6.20K | -- | -41.20K | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 36.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 102.70K | -52.20K |
| Cash from Financing | 130.00K | -6.20K | -- | 37.90K | -70.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.60K | 0.00 | -9.40K | -44.10K | -177.70K |